BLACKBURN BRENT K 4
4 · CV THERAPEUTICS INC · Filed Feb 26, 2009
Insider Transaction Report
Form 4
BLACKBURN BRENT K
SVP, Drug Discovery & Dev
Transactions
- Tax Payment
Common Stock
2009-02-25$15.58/sh−4,317$67,259→ 37,743 total - Exercise/Conversion
Common Stock
2009-02-25$15.58/sh+12,499$194,734→ 42,060 total - Exercise/Conversion
Restricted Stock Units
2009-02-25−12,499→ 45,313 totalExp: 2010-08-22→ Common Stock (12,499 underlying)
Holdings
- 6,730.908(indirect: By 401(k))
Common Stock
Footnotes (4)
- [F1]Shares held in the Reporting Person's name by the Issuer's 401(k) plan.
- [F2]Upon payout, the Reporting Person is entitled to receive 1 share of common stock for each 1 restricted stock unit.
- [F3]The vesting schedule for the grant of restricted stock units is (rounding up to the nearest whole RSU): on 2/22/2008, 7.5% of the RSUs shall vest; during the period commencing immediately following 2/22/2008 and ending on 8/22/2008, 0.0125% of the RSUs shall vest on the 22nd day of each month through 8/22/2008, such that 7.5% of the RSUs vest during such period and 15% of the RSUs are vested on 8/22/2008; during the period commencing immediately following 8/22/2008 and ending on 8/22/2009, 0.0208% of the RSUs shall become vested on the 22nd day of each month through 8/22/2009, such that 25% of the RSUs vest during such period and 40% of the RSUs are vested on 8/22/2009; during the period commencing immediately following 8/22/2009 and ending on 8/22/2010, 0.05% of the RSUs shall become vested on the 22nd day of each month through 8/22/2010, such that 60% of the RSUs vest during such period and 100% of the RSUs are vested on 8/22/2010.
- [F4]Shares that vest in accordance with the vesting schedule will be paid to the Reporting Person in whole shares of common stock on or about 2/22/2008, 2/22/2009, 2/22/2010 and 8/22/2010, with respect to shares that have vested prior to each such date and which have not yet been paid.